A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial

Morschhauser, Franck, Fitoussi, Olivier, Haioun, Corinne, Thieblemont, Catherine, Quach, Hang, Delarue, Richard, Glaisner, Sylvie, Gabarre, Jean +4 more·2013·European Journal of Cancer
DOI 10.1016/j.ejca.2013.04.029

Cited by (131)

Items 101–131 of 131

  1. Erratum to: Phase 1 study of darolutamide (ODM-201), a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer
    Nobuaki Matsubara, Hirofumi Mukai, Ako Hosono, Mai Onomura, Masaoki Sasaki, Yoko Yajima, Kensei Hashizume, Masanobu Yasuda, Miho Uemura, Christian Zurth · 2017 · Cancer Chemotherapy and Pharmacology
  2. Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agents
    Seda Serra Tolu, Caitlin K. Gribbin, Zhengming Chen, Madhav Rao Seshadri, Evelyn H. Orlando, Justin E. Grenet, Rajbir Toor, Alexander Daniel Sanjurjo, Hua-Jay Jeffery Cherng, Ahmed Sawas et al. · 2025 · Leukemia & lymphoma/Leukemia and lymphoma
  3. Novel agents and therapeutic advances in T cell lymphoma
    Yuko Shirouchi, Dai Maruyama · 2026 · International Journal of Hematology
  4. Targeted Approaches to T-Cell Lymphoma
    Sean Harrop, Chathuri Abeyakoon, Carrie van der Weyden, Henry Miles Prince · 2021 · Journal of Personalized Medicine
  5. Nodal Peripheral T-Cell Lymphoma: Therapeutic Challenges and Future Perspectives
    Ho Pui Jeff Lam, Faisal Amin, Suzanne O. Arulogun, Mary Gleeson · 2025 · Cancers
  6. Assessment of the Tolerability and Optimal Dosing of the Combination of Brentuximab Vedotin and Lenalidomide in Patients With Relapsed or Refractory T‐cell Lymphoma: Results of a Single‐centre Phase 1 Dose‐escalation Study
    Carrie van der Weyden, Mathias Bressel, Amit S. Khot, Henry Miles Prince, Michael John Dickinson · 2025 · eJHaem
  7. Investigational drugs for T-cell lymphoma
    David Ghez, Alina Danu, Vincent Ribrag · 2015 · Expert Opinion on Investigational Drugs
  8. Role of lenalidomide in the treatment of peripheral T-cell non-Hodgkin lymphomas
    Emanuele Cencini, Alberto Fabbri, Bianca Mecacci, Monica Bocchia · 2021 · World Journal of Clinical Oncology
  9. A Case of Chemotherapy-Refractory “THRLBCL like Transformation of NLPHL” Successfully Treated with Lenalidomide
    Mamatha Siricilla, Lydia Irwin, Andres Ferbér · 2018 · Case Reports in Oncological Medicine
  10. Peripheral T‐cell lymphomas
    Giulia Perrone, Chiara De Philippis, Lucia Farina, Paolo Corradini · 2015
  11. How I treat peripheral T-cell lymphomas
    Liliya Gamilevna Gorenkova, Ya. K. Mangasarova, Alla Mikhailovna Kovrigina, С К Кравченко, Клебанова Елизавета Евгеньевна, Madina Bagova, Yulia A. Chabaeva, Oleg V. Margolin, Eugene E. Zvonkov · 2024 · Гематология и трансфузиология
  12. Sustained yet non-curative response to lenalidomide in relapsed angioimmunoblastic T-cell lymphoma with acquired chidamide resistance: a case report with 10-year follow-up, genetic insights and literature review
    Juan Xu, Jie Huang, Liping Xie, Ting Liu, Jianjun Li, Xinchuan Chen, Zhigang Liu, Sha Zhao, Caigang Xu, Yu Wu · 2024 · Frontiers in Oncology
  13. SOHO State of the Art Updates and Next Questions | Update on Tailoring Therapy in T Cell Lymphomas
    Christina Moe, Jasmine M. Zain · 2025 · Clinical Lymphoma Myeloma & Leukemia
  14. Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics
    Joshua M. L. Casan, Xiaojing Ong, Carrie van der Weyden, Costas Kleanthes Yannakou, Joe Jiang Zhu, Criselle D’Souza, Paul Joseph Neeson, Henry Miles Prince · 2025 · Journal of Personalized Medicine
  15. Analysis Fecal calprotectin and immunochemical fecal occult blood test as dual biomarkers in colorectal cancer patients in relation to the radiological diagnosis and radiotherapy: Azerbaijan experience
    Narmin Bayramova, Gulnara Azizova, Malakhat Sultan Jahangir, Nazim Panahov, Nazanin Hasanzada, Ilhama Jahangirova, Vladimir Jurišić · 2026 · The European Physical Journal Special Topics
  16. RCLARITY : A Prospective Phase II Study of Rituximab Combined With Lenalidomide and Chidamide ( RLC ) for the Treatment of Relapsed/Refractory Angioimmunoblastic T‐Cell Lymphoma
    Cong Li, Tao Lei, Xiyue Xu, Jialiang Lu, Xiu Zhu, Zhilu Chen, Xiang Weng, Haifeng Yu, Xiaozhong Chen, Shuailing Peng et al. · 2026 · American Journal of Hematology
  17. Lenalidomide in adult T-cell leukaemia-lymphoma
    Alison J. Moskowitz · 2016 · The Lancet Haematology
  18. Radiologic and molecular remission of follicular T cell lymphoma treated with lenalidomide
    Yok‐Lam Kwong · 2016 · Annals of Hematology
  19. Standard of Care in T-Cell Lymphoma
    Alessandro Broccoli, Dai Chihara, Michelle A. Fanale, Pier Luigi Zinzani · 2018 · Essentials
  20. Successful Treatment of Chidamide and Cyclosporine for Refractory/Relapsed Angioimmunoblastic T Cell Lymphoma With Evans Syndrome: A Case Report With Long-Term Follow-Up
    Fang Zhu, Qiuhui Li, Huaxiong Pan, Yin Xiao, Tao Liu, Xinxiu Liu, Juan Li, Gang Wu, Liling Zhang · 2020 · Frontiers in Oncology
  21. Non Hodgkin’s Lymphoma T cell (PTCL-NOS) Post Salvage Radiation, a Long Term Survivor
    2021 · British Journal of Cancer Research
  22. Therapiestrategien der aggressiven Non-Hodgkin-Lymphome
    Gerhard Held, Gerald Georg Wulf · 2015 · Der Onkologe
  23. Lenalidomide in adult T-cell leukaemia-lymphoma
    David M. Phillips · 2016
  24. Systemic T-cell lymphoma
    Jasmine M. Zain · 2017 · Springer eBooks
  25. New Agents of Adult T-cell Leukemia/Lymphoma (ATL)
    Wataru Munakata, Kensei Tobinai · 2017 · Springer eBooks
  26. Tfh Lymphoma: Analysis of a RHOA Mutation & Establishment of a Pre-Clinical Model
    Rebecca L. Allchin · 2019 · Figshare
  27. Innovative Chemotherapy‐free Approaches for the Treatment of Peripheral T‐Cell Lymphoma
    Enrica Marchi, Ahmed Sawas, Helen Ma, Luigi Scotto, Francesca Montanari · 2021
  28. Advances in T-cell lymphomas and risk factors for CNS involvement
    Omar Elghawy, Nishwant S. Swami, Zachary A. Hing, Stefan Klaus Barta · 2025 · Leukemia & lymphoma/Leukemia and lymphoma
  29. Impact of Novel Agents on Allogeneic Hematopoietic Cell Transplantation in Patients with T-Cell Lymphomas
    Yoshitaka Inoue, Jun‐ichirou Yasunaga · 2025 · Cells
  30. Case Report: Angioimmunoblastic T-cell lymphoma with coexisting plasma cell tumors: three cases and review of the literature
    Yulin Yang, Xingshuo Bao, Wei Huang · 2025 · Frontiers in Oncology
  31. Unraveling the many faces of angioimmunoblastic T-cell lymphoma: clinical, pathological, and molecular heterogeneity
    Jia-Ping Chen, Peng Ke, Xiao Qiu, Qiu-Yuan Xian, Jing-Song Wu, Chun Feng, Hui-Jun Li, Yang Wang, Jihao Zhou · 2026 · Annals of Hematology